 |
| 메디톡스. (사진=메디톡스) |
[Alpha Biz=(Chicago) Reporter Paul Lee] Medytox announced on the 26th that the US Food and Drug Administration (FDA) refused to review the item license of the non-animal liquid botulinum toxin drug "MT10109L."
MT10109L is a liquid-type botulinum toxin drug designed to improve moderate and severe brow wrinkles and eye wrinkles.
Medytox applied for a product license for the product to FDA at the end of December last year, but FDA rejected the main review on the grounds that no specific verification test report was prepared regarding the substance.
Medytox said "We will discuss the matter with FDA and plan to supplement it and submit the application again."
AlphaBIZ 폴 리(hoondork1977@alphabiz.co.kr)
